# OnCo record iniparib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/iniparib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "iniparib" ;
  schema:name "Iniparib"@en ;
  schema:description "Billed as the first PARP inhibitor for triple-negative breast cancer, it failed its phase 3 in 2011. It turned out not to inhibit PARP at all."@en ;
  schema:url <https://onco.cc/drugs/iniparib/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Iniparib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q260286> ;
  schema:citation <https://aacrjournals.org/clincancerres/article/18/2/510/76892/A-Deep-Look-at-the-PARP-Inhibitor-Iniparib> ;
  onco:status "negative" ;
  onco:tag "failure", "lesson:wrong-drug" ;
  onco:modality "Small molecule (claimed PARP inhibitor)" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/talazoparib/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:trials <https://onco.cc/trials/nct00938652/>, <https://onco.cc/trials/nct01045304/>, <https://onco.cc/trials/nct01204125/> .